IGF2R and Insulin resistance: Furthermore, reducing levels of miR-143-3p in mice through anti-miR-143-3p injection into the tail vein was found to mitigate obesity-induced insulin resistance by modulating the expression of the insulin-like growth factor-2 receptor (Igf2r) [203].